Manchikanti L, Colliver J A, Grow J B, Demeyer R G, Hadley C H, Roush J R
Anesthesiology. 1986 Aug;65(2):180-5. doi: 10.1097/00000542-198608000-00009.
The dose-response effects of intravenous ranitidine given 45 min to 5 h earlier on gastric pH and volume were evaluated in six groups of 25 outpatients, each undergoing elective surgery under general anesthesia. Patients in Group 1 received no ranitidine and served as controls. Patients in Groups 2-6 received ranitidine intravenously in incremental doses of 0.5 mg X kg-1 body weight from 0.5 mg to 2.5 mg (Group 2, 0.5 mg; Group 3, 1.0 mg; Group 4, 1.5 mg; Group 5, 2.0 mg; and Group 6, 2.5 mg). Ninety-six per cent of patients in the control group (Group 1) had gastric pH less than or equal to 2.5 while 36% of the patients had gastric content volumes greater than or equal to 25 ml with pH less than or equal to 2.5. Ranitidine, in incremental doses of 05.-2.5 mg X kg-1 body weight, caused a significant reduction of gastric acidity and volume. The ED50 of ranitidine producing a gastric pH greater than 2.5 was 0.36 mg X kg-1, and the ED95 was 0.98 mg X kg-1 body weight. The ED95 of ranitidine producing a gastric volume less than 25 ml was 1.96 mg X kg-1. At the dose of 1.5 mg X kg-1 of ranitidine, 100% of the patients had gastric contents with pH greater than 2.5. The proportion of patients with volume less than 25 ml was 68% with ranitidine, 0.5 mg X kg-1, and gradually increased to 100% with 2.5 mg X kg-1 body weight.(ABSTRACT TRUNCATED AT 250 WORDS)
在六组每组25名门诊患者中评估了提前45分钟至5小时静脉注射雷尼替丁对胃pH值和容量的剂量反应效应,这些患者均接受全身麻醉下的择期手术。第1组患者未接受雷尼替丁,作为对照组。第2 - 6组患者静脉注射雷尼替丁,剂量从0.5毫克至2.5毫克,以0.5毫克/千克体重递增(第2组,0.5毫克;第3组,1.0毫克;第4组,1.5毫克;第5组,2.0毫克;第6组,2.5毫克)。对照组(第1组)96%的患者胃pH值小于或等于2.5,而36%的患者胃内容物容量大于或等于25毫升且pH值小于或等于2.5。雷尼替丁剂量从0.5 - 2.5毫克/千克体重递增时,可显著降低胃酸度和容量。使胃pH值大于2.5的雷尼替丁半数有效剂量(ED50)为0.36毫克/千克体重,95%有效剂量(ED95)为0.98毫克/千克体重。使胃容量小于25毫升的雷尼替丁ED95为1.96毫克/千克体重。雷尼替丁剂量为1.5毫克/千克体重时,100%的患者胃内容物pH值大于2.5。雷尼替丁剂量为0.5毫克/千克体重时,胃容量小于25毫升的患者比例为68%,随着剂量增至2.5毫克/千克体重,该比例逐渐增至100%。(摘要截选至250词)